BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 9949892)

  • 1. [Treatment of diabetes insipidus with Minirin. Switch from nasal to oral administration].
    Czernichow P
    Ann Endocrinol (Paris); 1998 Dec; 59(5):407-9. PubMed ID: 9949892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of central diabetes insipidus using oral DDAVP. Comparison with intranasal treatment].
    Carraro A; Fano M; Porcella E; Bernareggi V; Giusti M
    Minerva Endocrinol; 1991; 16(3):141-5. PubMed ID: 1806811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Long-term treatment of central diabetes insipidus with oral DDAVP].
    Carraro A; Fano M; Cuttica M; Bernareggi V; Giusti M; Giordano G
    Minerva Endocrinol; 1992; 17(4):189-93. PubMed ID: 1308923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical evaluation of desmopressin (DDAVP) in diabetes insipidus: solution vs tablets].
    Rampazzo AL; Boscaro M; Mantero F; Piccitto R
    Minerva Endocrinol; 1992; 17(1):37-41. PubMed ID: 1495453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effectiveness of and tolerability to oral desmopressin in the treatment of central diabetes insipidus].
    Merola B; Caruso E; De Chiara G; Rossi E; Longobardi S; Colao A; Brusco G; Lombardi G; Biraghi M
    Minerva Med; 1992 Dec; 83(12):805-13. PubMed ID: 1491760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central diabetes insipidus in children. Antidiuretic effect and pharmacokinetics of intranasal and peroral 1-deamino-8-D-arginine vasopressin.
    Fjellestad-Paulsen A; Tubiana-Rufi N; Harris A; Czernichow P
    Acta Endocrinol (Copenh); 1987 Jul; 115(3):307-12. PubMed ID: 3618082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of cranial diabetes insipidus with oral desmopressin (DDAVP).
    Cunnah D; Ross G; Besser GM
    Clin Endocrinol (Oxf); 1986 Mar; 24(3):253-7. PubMed ID: 3708875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The treatment of patients with diabetes insipidus by a synthetic analogue of vasopressin, DDAVP (author's transl)].
    Tanae A; Shimizu K; Yoshida S
    Nihon Naibunpi Gakkai Zasshi; 1978 May; 54(5):676-91. PubMed ID: 689212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical evaluation of 2 new formulations of desmopressin (DDAVP), nasal spray and tablets, in the therapy of diabetes insipidus].
    Gelli D; Riolo A; Carioni E; Albano M
    Minerva Endocrinol; 1989; 14(4):227-32. PubMed ID: 2636699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Desmopressin tablet treatment in nocturnal enuresis.
    Stenberg A; Läckgren G
    Scand J Urol Nephrol Suppl; 1995; 173():95-9. PubMed ID: 8719577
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of the antidiuretic effects of single intravenous and intranasal doses of DDAVP in diabetes insipidus.
    Radó JP; Marosi J; Fischer J
    Pharmacology; 1977; 15(1):40-5. PubMed ID: 840889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics, pharmacodynamics, long-term efficacy and safety of oral 1-deamino-8-D-arginine vasopressin in adult patients with central diabetes insipidus.
    Lam KS; Wat MS; Choi KL; Ip TP; Pang RW; Kumana CR
    Br J Clin Pharmacol; 1996 Sep; 42(3):379-85. PubMed ID: 8877030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioavailability and pharmacokinetics of desmopressin in elderly men.
    Hougaard C; Matthiesen TB; Rittig S; Djurhuus JC
    Scand J Urol Nephrol Suppl; 1997; 183():53-4. PubMed ID: 9165608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The treatment of diabetes insipidus in 1999].
    Ajzenberg C; Warnet A
    Rev Med Interne; 1999 Aug; 20 Suppl 3():399s-400s. PubMed ID: 10480192
    [No Abstract]   [Full Text] [Related]  

  • 15. Oral administration of diluted nasal desmopressin in managing neonatal central diabetes insipidus.
    Mavinkurve M; McGrath N; Johnston N; Moloney S; Murphy NP; Hawkes CP
    J Pediatr Endocrinol Metab; 2017 May; 30(6):623-628. PubMed ID: 28599389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral desmopressin in central diabetes insipidus.
    Westgren U; Wittström C; Harris AS
    Arch Dis Child; 1986 Mar; 61(3):247-50. PubMed ID: 3963868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroral treatment of diabetes insipidus with a polypeptide hormone analog, desmopressin.
    Hammer M; Vilhardt H
    J Pharmacol Exp Ther; 1985 Sep; 234(3):754-60. PubMed ID: 4032289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose intranasal desmopressin (DDAVP) for uremic bleeding.
    Ozen S; Saatci U; Bakkaloglu A; Ozdemir S; Ozdemir O; Besbas N
    Nephron; 1997; 75(1):119-20. PubMed ID: 9031290
    [No Abstract]   [Full Text] [Related]  

  • 19. Desmopressin (DDAVP) for enuresis, diabetes insipidus, and..
    Gaines KK
    Urol Nurs; 2004 Dec; 24(6):520-3. PubMed ID: 15658741
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of a new antidiuretic agent, desmopressin acetate (DDAVP).
    Kosman ME
    JAMA; 1978 Oct; 240(17):1896-7. PubMed ID: 691204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.